Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 A SPAC I Acquisition A ASCA Mar 20, 2023 10.33 0.00   
 A SPAC I Acquisition Corp. - Unit ASCAU Mar 20, 2023 10.48 0.00   
 A SPAC II Acquisition ASCB Mar 20, 2023 10.40 +0.39   
 A SPAC II Acquisition Corp. - Unit ASCBU Mar 20, 2023 10.42 0.00   
 A-Mark Precious Metals AMRK Mar 20, 2023 29.78 -0.12   
 a.k.a Brands AKA Mar 20, 2023 0.70 -20.82   
 A.O Smith AOS Mar 20, 2023 66.45 +1.50   
 A10 Networks ATEN Mar 20, 2023 14.61 +1.46   
 A2Z Smart Technologies Corp. - AZ Mar 20, 2023 1.26 +1.61   
 AAA - A Rated Corporate Bond Ishares QLTA Mar 20, 2023 47.19 -0.27   
 Aadi Bioscience AADI Mar 20, 2023 7.59 +0.93   
 AAON AAON Mar 20, 2023 89.79 +0.51   
 AAR Corp. AIR Mar 20, 2023 51.86 +2.41   
 Aarons AAN Mar 20, 2023 9.38 -0.85   
 ABB ABB Mar 20, 2023 32.56 +1.78   
 Abbott Laboratories ABT Mar 20, 2023 97.87 +0.89   
 AbbVie ABBV Mar 20, 2023 156.12 +1.23   
 Abcam ADR ABCM Mar 20, 2023 13.42 -3.73   
 AbCellera Biologics ABCL Mar 20, 2023 7.57 +2.44   
 Abeona Therapeutics ABEO Mar 20, 2023 2.30 -3.77   
 Abercrombie & Fitch ANF Mar 20, 2023 26.06 +0.39   
 Aberdeen Asia-Pacificome Fund FAX Mar 20, 2023 2.65 -0.75   
 Aberdeen Australia Equity Fund IAF Mar 20, 2023 4.28 -0.93   
 Aberdeen Emerging Markets AEF Mar 20, 2023 5.05 +0.80   
 Aberdeen Global FCO Mar 20, 2023 5.07 -0.99   
 Aberdeen Income Credit Strategies ACP Mar 20, 2023 6.75 -0.88   
 Aberdeen Income Credit Strategies Pref ACP-A Mar 20, 2023 21.18 +0.47   
 Aberdeen Japan Equity JEQ Mar 20, 2023 5.33 +0.19   
 Aberdeen Standard Global Infrastructure ASGI Mar 20, 2023 17.41 +0.23   
 ABG Acquisition I A ABGI Mar 20, 2023 10.19 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+